CA
RLAY icon

Cliff Asness’s Relay Therapeutics RLAY Stock Holding History

Cliff Asness’s Portfolio RLAY Stock Details RLAY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$23.9M Sell
1,279,473
-10,559
-0.8% -$153K 0.01% 1103
2026
Q1 		$12.8M Buy
1,290,032
+126,908
+11% +$1.14M 0.01% 1228
2025
Q4 		$9.84M Sell
1,163,124
-137,912
-11% -$984K 0.01% 1225
2025
Q3 		$6.79M Buy
1,301,036
+217,571
+20% +$830K ﹤0.01% 1276
2025
Q2 		$3.75M Buy
1,083,465
+718,519
+197% +$2.14M ﹤0.01% 1445
2025
Q1 		$956K Buy
364,946
+38,812
+12% +$152K ﹤0.01% 2043
2024
Q4 		$1.34M Buy
326,134
+302,742
+1,294% +$1.65M ﹤0.01% 1731
2024
Q3 		$166K Sell
23,392
-43,851
-65% -$328K ﹤0.01% 2601
2024
Q2 		$438K Buy
67,243
+52,693
+362% +$360K ﹤0.01% 2104
2024
Q1 		$121K Buy
14,550
+3,049
+27% +$29.7K ﹤0.01% 2320
2023
Q4 		$127K Buy
+11,501
New +$97K ﹤0.01% 2265

Other funds holding RLAY

SIAU
SB Investment Advisers (UK) London, United Kingdom $7.66B AUM 20.12% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return

Cliff Asness's RLAY Position: Q2 2026 in Review

Cliff Asness reduced its Relay Therapeutics (RLAY) stake by 0.82% in Q2 2026, selling an estimated $153K and leaving 1,279,473 shares worth $23.9M. The position accounts for 0.01% of the portfolio, ranked #1103.

Cliff Asness first reported a position in RLAY in Q4 2023 and has held it in 11 quarters since. 256 funds tracked by Wall St. Rank hold RLAY as of Q2 2026.

  • Cliff Asness held 1,279,473 shares of Relay Therapeutics worth $23.9M as of Q2 2026.
  • Cliff Asness sold 10,559 Relay Therapeutics shares in Q2 2026, an estimated $153K.
  • Relay Therapeutics made up 0.01% of Cliff Asness's portfolio in Q2 2026, its #1103 holding.
  • Cliff Asness first reported a position in Relay Therapeutics in Q4 2023 and has held it in 11 quarters since.
  • 256 funds tracked by Wall St. Rank held Relay Therapeutics as of Q2 2026.

Based on AQR Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.